SU5416

DRUG3 trials

Sponsors

SUGEN, University of Chicago

Conditions

HIV InfectionsProstate CancerSarcoma, Kaposi

Phase 1

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

CompletedNCT00026377

University of ChicagoProstate Cancer

Start: 2001-11-30End: 2003-04-30Updated: 2013-09-05

Phase 2

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

CompletedNCT00005931

SUGENHIV Infections, Sarcoma, Kaposi

Target: 30Updated: 2005-06-24

Unknown Phase

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

CompletedNCT00002226

SUGENHIV Infections, Sarcoma, Kaposi

Target: 30Updated: 2005-06-24